Cargando…

Survival analysis of patients taking dabigatran who consulted an emergency department for acute bleeding: a first alarm

Detalles Bibliográficos
Autores principales:	Arlet, OA, Notebaert, EN, Paquet, JP, Daoust, RD, Vincent, MV, Chauny, JC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642636/ http://dx.doi.org/10.1186/cc12285

Ejemplares similares

Conflicting results between V/Q SPECT and angioscan in pulmonary embolism: what to do?
por: Martel, JM, et al.
Publicado: (2013)

No impact of a massive transfusion protocol on coagulopathy and mortality at a level 1 trauma center: why?
por: Bourassa-Fulop, C, et al.
Publicado: (2012)

Is adequate pain relief and time to analgesia associated with emergency department length of stay? A retrospective study
por: Sokoloff, Catalina, et al.
Publicado: (2014)

Impact of age, sex and route of administration on adverse events after opioid treatment in the emergency department: A retrospective study
por: Daoust, Raoul, et al.
Publicado: (2015)

In trauma, when used in the emergency department, do viscoelastic hemostatic tests decrease mortality? A systematic review
por: Cousineau, J, et al.
Publicado: (2015)

Relationship between acute pain trajectories after an emergency department visit and chronic pain: a Canadian prospective cohort study
por: Daoust, Raoul, et al.
Publicado: (2020)

Evaluation of Interventions to Reduce Opioid Prescribing for Patients Discharged From the Emergency Department: A Systematic Review and Meta-analysis
por: Daoust, Raoul, et al.
Publicado: (2022)

Impact of vitamin C on the reduction of opioid consumption after an emergency department visit for acute musculoskeletal pain: a double-blind randomised control trial protocol
por: Daoust, Raoul, et al.
Publicado: (2023)

Management of dabigatran-induced bleeding: expert statement
por: Fries, Dietmar, et al.
Publicado: (2013)

Association Between the Change in Total Bilirubin and Risk of Bleeding Among Patients With Nonvalvular Atrial Fibrillation Taking Dabigatran
por: Xiong, Yurong, et al.
Publicado: (2020)

Quantity of opioids consumed following an emergency department visit for acute pain: a Canadian prospective cohort study
por: Daoust, Raoul, et al.
Publicado: (2018)

Peripheral leukocyte count and risk of bleeding in patients with non-valvular atrial fibrillation taking dabigatran: a real-world study
por: Zhou, Wei, et al.
Publicado: (2019)

Effect of β-blockers and calcium channel blockers on shock index predictability in patients suffering from urosepsis
por: Cliche, J, et al.
Publicado: (2013)

Accuracy of the shock index and various modified shock indexes to predict early mortality in patients suffering from gastrointestinal haemorrhage
por: Bourque, J St-Cyr, et al.
Publicado: (2013)

Idarucizumab for a traumatic head injury patient taking dabigatran
por: Maruyama, Shuhei, et al.
Publicado: (2018)

Percutaneous nephrolithotomy; alarming variables for postoperative bleeding
por: Said, Shakhawan H.A., et al.
Publicado: (2017)

Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran
por: Curto, Adrian, et al.
Publicado: (2017)

Use of a specific antidote to dabigatran (idarucizumab) reduces blood loss and mortality in dabigatran-induced and trauma-induced bleeding in pigs
por: Honickel, M, et al.
Publicado: (2014)

Association between body mass index and the risk of bleeding in elderly patients with non-valvular atrial fibrillation taking dabigatran: a cohort study
por: Li, Ming-Hui, et al.
Publicado: (2020)

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban
por: Charlton, Blake, et al.
Publicado: (2018)

Dabigatran Plasma Measurement to Guide the Management of Acute Bleeding and Thrombotic Complications
por: Tala, Maurizio, et al.
Publicado: (2018)

Dabigatran: Clinical correlation of drug and its dose with risk of stroke and bleeding
por: Shaji, Anitta, et al.
Publicado: (2023)

Recovery of Visual Function after Administration of Dabigatran Etexilate
por: Schönfeld, Carl-Ludwig, et al.
Publicado: (2014)

Arabidopsis, tobacco, nightshade and elm take insect eggs as herbivore alarm and show similar transcriptomic alarm responses
por: Lortzing, Tobias, et al.
Publicado: (2020)

Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
por: Riario Sforza, Gian Galeazzo, et al.
Publicado: (2018)

Risk factors and prevention of dabigatran‐related gastrointestinal bleeding in patients with atrial fibrillation
por: Nantsupawat, Teerapat, et al.
Publicado: (2017)

Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures
por: Andrade, Marcus Vinicius Santos, et al.
Publicado: (2018)

Real‐world use of idarucizumab for dabigatran reversal in three cases of serious bleeding
por: Gendron, Nicolas, et al.
Publicado: (2017)

Dabigatran Acylglucuronide, the Major Metabolite of Dabigatran, Shows a Weaker Anticoagulant Effect than Dabigatran
por: Kim, Jong-Min, et al.
Publicado: (2022)

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study
por: Abraham, Neena S, et al.
Publicado: (2015)

Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed(,,)
por: Milling, Truman J., et al.
Publicado: (2016)

Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed
por: Milling, Truman J., et al.
Publicado: (2016)

Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case report
por: Jia, Yu, et al.
Publicado: (2022)

The Dabigatran debate
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Who Consults an Adult Psychiatric Emergency Department? Pertinence of Admissions and Opportunities for Telepsychiatry
por: Costanza, Alessandra, et al.
Publicado: (2020)

Risk of Gastrointestinal Bleeding Among Dabigatran Users – A Self Controlled Case Series Analysis
por: Tang, Wenze, et al.
Publicado: (2017)

Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2017)

Major bleeding events in octagenarians associated with drug interactions between dabigatran and P-gp inhibitors
por: Bernier, Marjorie, et al.
Publicado: (2019)

The ‘SILENT Alarm’: When History Taking Reveals a Potentially Fatal Toxicity
por: Anani, Sapir, et al.
Publicado: (2018)

Intermittent Herald Bleeding: An Alarm for Prevention of the Exsanguination of Aortoenteric Fistula before it Arrives
por: Yazdanpanah, Kambiz, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ne590vtip40dgkfg0vba3fk491